To amend the Harmonized Tariff Schedule for the United States to establish a new subheading in chapter 39 for silicone prosthetics for women who are breast cancer survivors and a new subheading in chapter 90 for mastectomy bras.
This bill proposes amendments to the Harmonized Tariff Schedule of the United States (HTS) to create specific classifications for products essential to breast cancer survivors. It establishes a new subheading 3926.20.61 within chapter 39 for silicone prosthetic breast forms used with mastectomy brassieres. Additionally, it introduces a new subheading 9021.10.60 in chapter 90 specifically for mastectomy brassieres . Effective January 1, 2027, the legislation sets the general duty rate for both these newly classified items at 0%. This measure is intended to eliminate tariffs on these crucial post-mastectomy products, thereby making them more accessible and affordable for women recovering from breast cancer.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Ways and Means.
Introduced in House
Referred to the House Committee on Ways and Means.
Health
To amend the Harmonized Tariff Schedule for the United States to establish a new subheading in chapter 39 for silicone prosthetics for women who are breast cancer survivors and a new subheading in chapter 90 for mastectomy bras.
USA119th CongressHR-10147| House
| Updated: 8/24/2026
This bill proposes amendments to the Harmonized Tariff Schedule of the United States (HTS) to create specific classifications for products essential to breast cancer survivors. It establishes a new subheading 3926.20.61 within chapter 39 for silicone prosthetic breast forms used with mastectomy brassieres. Additionally, it introduces a new subheading 9021.10.60 in chapter 90 specifically for mastectomy brassieres . Effective January 1, 2027, the legislation sets the general duty rate for both these newly classified items at 0%. This measure is intended to eliminate tariffs on these crucial post-mastectomy products, thereby making them more accessible and affordable for women recovering from breast cancer.